Gustavo Giraldo - CVS HEALTH Head Benefits
CVS Stock | 13.74 0.23 1.65% |
Executive
Gustavo Giraldo is Head Benefits of CVS HEALTH CDR
Age | 52 |
Address | One CVS Drive, Woonsocket, RI, United States, 02895 |
Phone | 401 765 1500 |
Web | https://www.cvshealth.com |
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Brent Hyder | SalesforceCom CDR | 59 | |
LLB BA | CI Financial Corp | N/A | |
Iain Kennedy | Rogers Communications | N/A | |
Terrie Tweddle | Rogers Communications | N/A | |
Jane Webb | Quorum Information Technologies | N/A | |
Joe Allanson | SalesforceCom CDR | 60 | |
Imen Zitouni | Intact Financial Corp | N/A | |
Kenneth Anderson | Intact Financial Corp | N/A | |
Bradley Howard | CI Financial Corp | N/A | |
Julie Silcox | CI Financial Corp | N/A | |
Marisa Fabiano | Rogers Communications | N/A | |
Bruce Atkinson | Quorum Information Technologies | N/A | |
Suzanne DiBianca | SalesforceCom CDR | N/A | |
Sarah Franklin | SalesforceCom CDR | N/A | |
Bill Patterson | SalesforceCom CDR | N/A | |
Juan Perez | SalesforceCom CDR | 57 | |
Marisa Wyse | Rogers Communications | N/A | |
Sundeep Reddy | SalesforceCom CDR | 50 | |
Vala Afshar | SalesforceCom CDR | N/A | |
Stephen Fisher | SalesforceCom CDR | 60 | |
John JD | SalesforceCom CDR | N/A |
Management Performance
Return On Equity | 0.067 | ||||
Return On Asset | 0.0237 |
CVS HEALTH CDR Leadership Team
Elected by the shareholders, the CVS HEALTH's board of directors comprises two types of representatives: CVS HEALTH inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS HEALTH's management team and ensure that shareholders' interests are well served. CVS HEALTH's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS HEALTH's outside directors are responsible for providing unbiased perspectives on the board's policies.
Katerina Guerraz, Chief VP | ||
Sreekanth MD, Executive Officer | ||
Vijay Patel, Senior CoFounder | ||
James Clark, Controller VP | ||
Prem PharmD, Group President | ||
David Falkowski, Executive Officer | ||
FACEP MD, VP Officer | ||
Laurence McGrath, Senior Relations | ||
Laurie Havanec, Executive Officer | ||
David CEBS, Executive Caremark | ||
Tilak Mandadi, Data, Digital | ||
Thomas Cowhey, Executive CFO | ||
Gustavo Giraldo, Head Benefits | ||
Samrat Esq, Chief VP | ||
Heidi Capozzi, Executive Officer | ||
Roger Farah, Executive Board | ||
Sheryl Burke, Chief Responsibility | ||
MPP MD, Senior President | ||
Karen Lynch, CEO President | ||
Michelle Peluso, Executive Officer |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS HEALTH a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.067 | ||||
Return On Asset | 0.0237 | ||||
Profit Margin | 0.01 % | ||||
Operating Margin | 0.02 % | ||||
Current Valuation | 199.97 B | ||||
Shares Outstanding | 6.91 B | ||||
Price To Book | 0.91 X | ||||
Price To Sales | 0.28 X | ||||
Revenue | 367.25 B | ||||
Gross Profit | 53.46 B |
Pair Trading with CVS HEALTH
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS HEALTH position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS HEALTH will appreciate offsetting losses from the drop in the long position's value.Moving against CVS Stock
The ability to find closely correlated positions to CVS HEALTH could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS HEALTH when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS HEALTH - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS HEALTH CDR to buy it.
The correlation of CVS HEALTH is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS HEALTH moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS HEALTH CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS HEALTH can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in CVS Stock
CVS HEALTH financial ratios help investors to determine whether CVS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVS with respect to the benefits of owning CVS HEALTH security.